Novartis’ Kisqali receives US FDA approval to reduce risk of …
WEB1 day ago · Novartis announced that the US Food and Drug Administration (FDA) has approved Kisqali (ribociclib) in combination with an aromatase inhibitor (AI) for the adjuvant treatment of people with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) stage II and III early ...
US FDA approves AstraZeneca’s Fasenra to treat eosinophilic ...
WEB1 day ago · Cambridge, UK. Thursday, September 19, 2024, 11:00 Hrs [IST] AstraZeneca’s Fasenra (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). EGPA is a rare, immune-mediated vasculitis that can result in damage to multiple organs, and without treatment, can be …
Merck gets US FDA approval for Keytruda plus pemetrexed
WEB1 day ago · Merck, known as MSD outside of the United States and Canada, announced the US Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, in combination with pemetrexed and platinum chemotherapy, for the first-line treatment of adult patients with unresectable advanced or ...
Study shows use of metformin in adults with diabetes linked to …
WEB1 day ago · An earlier NIH-supported clinical trial in 2023 showed that treatment with metformin, commonly used to help control blood sugar, reduced the risk of long Covid by as much as 40% in nearly 1,300 US adults with overweight or obesity, most of whom did not have diabetes. To see if the drug had a similar effect in people with diabetes, researchers ...
JB Pharma accelerates global expansion and diversifies into …
WEB1 day ago · JB Pharma has announced significant strides in its strategic growth, diversifying into progressive therapies while strengthening its presence in international markets. Over the past three years, the company has seen robust growth, with revenue increasing at a 19% compound annual growth rate (CAGR ...
News - Pharmabiz.com
WEBSep 13, 2024 · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & documents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing
Daiichi Sankyo & AstraZeneca's Enhertu gets US FDA …
WEBAug 20, 2024 · Daiichi Sankyo & AstraZeneca's Enhertu gets US FDA breakthrough therapy designation for certain patients with HER2 low or HER2 ultralow metastatic breast cancer
Pfizer, BioNTech receive US FDA approval & authorization for …
WEBSaturday, August 24, 2024, 09:00 Hrs [IST] Pfizer Inc. and BioNTech SE announced that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application for individuals 12 years of age and older (COMIRNATY (Covid-19 Vaccine, mRNA), and granted emergency use authorization for individuals 6 …
Boehringer Ingelheim’s Cyltezo to treat multiple chronic …
WEBFriday, May 3, 2024, 11:00 Hrs [IST] Boehringer Ingelheim Group, one of the largest producers of biologic medicines in the world, announced that the US Food and Drug Administration (FDA) has approved the high-concentration, citrate-free formulation of Cyltezo (adalimumab-adbm), the company's interchangeable biosimilar to Humira (adalimumab), to ...
AstraZeneca completes acquisition of clinical-stage biotech …
WEBJul 16, 2024 · Cambridge, UK. Tuesday, July 16, 2024, 10:00 Hrs [IST] AstraZeneca announced the successful completion of the acquisition of Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases. The acquisition bolsters the Alexion, AstraZeneca Rare Disease late-stage pipeline and expands on ...
Skip to content